SOPHiA GENETICS Revenue and Competitors

Saint Sulpice, Switzerland

Location

$250.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SOPHiA GENETICS's estimated annual revenue is currently $37.4M per year.(i)
  • SOPHiA GENETICS's estimated revenue per employee is $73,092
  • SOPHiA GENETICS's total funding is $250.2M.
  • SOPHiA GENETICS's current valuation is $902.3M. (January 2022)

Employee Data

  • SOPHiA GENETICS has 511 Employees.(i)
  • SOPHiA GENETICS grew their employee count by -2% last year.

SOPHiA GENETICS's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
SVP – Chief Technology OfficerReveal Email/Phone
3
VP, Global Talent ManagementReveal Email/Phone
4
Head Corporate Development and Commercial AnalyticsReveal Email/Phone
5
Head Strategy and Partnerships, BiopharmaReveal Email/Phone
6
SVP & CSOReveal Email/Phone
7
VP Business DevelopmentReveal Email/Phone
8
VP Sales, USReveal Email/Phone
9
Head Architecture and Technology InnovationReveal Email/Phone
10
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16.1M10428%N/AN/A
#2
$37.4M511-2%$250.2MN/A
#3
$60.3M389-5%N/AN/A
#4
$31.8M20522%N/AN/A
#5
$1.9M120%N/AN/A
#6
$2.5M16-43%N/AN/A
#7
$7.9M512%N/AN/A
#8
$1.1M717%N/AN/A
#9
$0.6M40%N/AN/A
#10
$10.4M6781%N/AN/A
Add Company

What Is SOPHiA GENETICS?

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing. Our mission is to bring data analytics solutions to market, to support healthcare professionals by maximizing the power of Data-Driven Medicine. We achieve this mission through the global adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition and machine learning. This enables SOPHiA to provide equal benefits to all users, unite experts in a gold standard health tech platform, and motivate expert knowledge sharing for a sustainable impact on future patients. We want to contribute to make the global healthcare system more sustainable. It is our strong belief that digital technologies are the key to unlocking the era of Data-Driven Medicine, where secure data pooling and knowledge sharing will be extremely valuable for patients. By helping healthcare professionals leverage their expertise and work together as a community, patients all over the world can receive equal access to better diagnoses and treatments. Combining the first two pillars of Data-Driven Medicine, Genomics and Radiomics, we can ensure that the data used to help patients today will also benefit the patients of tomorrow. Follow us on Twitter @SOPHiAGENETICS

keywords:Biotechnology

$250.2M

Total Funding

511

Number of Employees

$37.4M

Revenue (est)

-2%

Employee Growth %

$902.3M

Valuation

N/A

Accelerator

SOPHiA GENETICS News

2022-04-20 - SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles ...

BOSTON and LAUSANNE, Switzerland, April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine,...

2022-04-13 - Comparing Ikena Oncology (NASDAQ:IKNA) and SOPHiA ...

Get SOPHiA GENETICS alerts: 29.1% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 58.8% of Ikena Oncology shares...

2022-04-13 - Zacks: Analysts Anticipate SOPHiA GENETICS SA (NASDAQ:SOPH ...

Zacks: Analysts Anticipate SOPHiA GENETICS SA (NASDAQ:SOPH) Will Announce Quarterly Sales of $11.01 Million. Posted by admin on Apr 17th, 2022.

2021-07-28 - SOPHiA GENETICS goes public at NASDAQ raising USD 234 million

SOPHiA GENETICS goes public at NASDAQ raising USD 234 million 28.07.2021 17:49, Guillaume Tinsel linkedIn facebook twitter instagram youtube --> Lausanne-based SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced t ...

2021-07-27 - SOPHiA GENETICS : Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement

BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the closing of its initial public offering of 13,000,000 ordinary shares ...